This inventor holds 1 USPTO granted patent. Top assignee: Intron Biotechnology, Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations of Jung Mi Kim in Bacteriophage Research
Introduction
Jung Mi Kim is a notable inventor based in Gwangju, South Korea. She has made significant contributions to the field of bacteriophage research, particularly in developing compositions that can prevent and treat infections. Her work is characterized by a strong focus on innovative solutions to combat bacterial infections.
Latest Patents
Jung Mi Kim holds 1 patent for her invention, which involves a composition that includes an isolated bacteriophage Str-PAP-1. This bacteriophage has the unique ability to specifically kill cells by infecting them. The composition may be utilized in preventing and treating infections, showcasing its potential in medical applications. The bacteriophage Str-PAP-1 is distinguished by its genome, represented by the nucleotide sequence of SEQ. ID. NO: 1.
Career Highlights
Jung Mi Kim is currently employed at Intron Biotechnology, Inc., where she continues to advance her research in bacteriophage technology. Her work at the company has positioned her as a key figure in the development of innovative therapeutic solutions.
Collaborations
Some of her notable coworkers include Soo Youn Jun and An Sung Kwon, who contribute to the collaborative efforts in their research projects.
Conclusion
Jung Mi Kim's innovative work in bacteriophage research exemplifies the potential of using biological agents to address bacterial infections. Her contributions are paving the way for new therapeutic strategies in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile